ARL4C and colorectal carcinoma: Building on these observations, the present study aimed to systematically dissect the role and mechanisms of ARL4C in mediating oxaliplatin resistance and distant metastasis in CRC, and to explore small-molecule inhibitors targeting ARL4C as potential therapeutic agents.